Lifeward (LFWD)
NASDAQ:LFWD
Want to see LFWD full AI Analyst Report?
LFWD Stock Chart & Stats
$6.79
-$0.33(-14.93%)
At close: 4:00 PM EST
$6.79
-$0.33(-14.93%)
Day’s Range― - ―
52-Week Range$4.14 - $15.36
Previous CloseN/A
Volume483.00K
Average Volume (3M)316.99K
Market Cap
$17.84M
Enterprise Value$8.17M
Total Cash (Recent Filing)$11.42M
Total Debt (Recent Filing)$8.81M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Aug 12, 2026EPS Estimate
-0.81Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-19.66
Shares Outstanding2,814,409
10 Day Avg. Volume318,606
30 Day Avg. Volume316,993
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)9.55
Price to Sales (P/S)3.64
P/FCF Ratio-4.77
Enterprise Value/Market Cap0.46
Enterprise Value/Revenue0.39
Enterprise Value/Gross Profit1.07
Enterprise Value/Ebitda-0.37
Forecast
1Y Price Target
$10.00Price Target Upside47.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-2.47
Revenue Forecast (FY)$30.11M
Bulls Say, Bears Say
Bulls Say
Financial PerformanceLifeward's Q4 results showed a gross margin of 45.4%, ahead of the 41.9% expectation.
Market PenetrationManagement plans to expand market penetration of ReWalk Personal among patients covered by Centers for Medicare & Medicaid Services, workers compensation insurance and US commercial insurers.
PartnershipsRecent developments help diversify Lifeward's business through an exclusive partnership with CorLife and an expanded distribution agreement with MYOLYN.
Bears Say
EarningsThe company reported a net loss of $1.73 per share, compared to consensus estimated net loss of $0.31 per share.
Reimbursement DelaysThe company continues to experience longer than expected time to receive CMS reimbursement.
Revenue GuidanceLifeward's FY2025 revenue guidance was mixed, showing lower revenue than forecasted despite a better bottom line.
Lifeward News
LFWD FAQ
What was Lifeward’s price range in the past 12 months?
Lifeward lowest stock price was $4.14 and its highest was $15.36 in the past 12 months.
What is Lifeward’s market cap?
Lifeward’s market cap is $17.84M.
When is Lifeward’s upcoming earnings report date?
Lifeward’s upcoming earnings report date is Aug 12, 2026 which is in 81 days.
How were Lifeward’s earnings last quarter?
Lifeward released its earnings results on May 15, 2026. The company reported -$3.13 earnings per share for the quarter, missing the consensus estimate of -$1.18 by -$1.95.
Is Lifeward overvalued?
According to Wall Street analysts Lifeward’s price is currently Undervalued.
Does Lifeward pay dividends?
Lifeward does not currently pay dividends.
What is Lifeward’s EPS estimate?
Lifeward’s EPS estimate is -0.81.
How many shares outstanding does Lifeward have?
Lifeward has 2,814,409 shares outstanding.
What happened to Lifeward’s price movement after its last earnings report?
Lifeward reported an EPS of -$3.13 in its last earnings report, missing expectations of -$1.18. Following the earnings report the stock price went up 1.592%.
Which hedge fund is a major shareholder of Lifeward?
Currently, no hedge funds are holding shares in LFWD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lifeward
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.
LFWD Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Balanced mix of strategic, financial and operational positives (acquisitions, stronger cash position, ReWalk growth, cost reductions and reduced cash burn) offset by meaningful near-term operational headwinds (22% revenue decline, 800 bps gross margin compression, increased GAAP loss and manufacturing/supply chain disruptions). Management expects to resolve AlterG timing issues across Q2–Q3, sees a path to profitability and holds revenue expectation similar to prior year but retains execution risk during the transition.View all LFWD earnings summariesLFWD Stock 12 Month Forecast
Average Price Target
$10.00
▲(47.28% Upside)
Technical Analysis
Ownership Overview
29.44% Insiders
<0.01% Mutual Funds
― Other Institutional Investors
70.56% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---